Effect of unani formulation in PCOS: A case report
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
PCOS is the most common endocrine pathology in females of reproductive worldwide. The prevalenceranges between 5% and 15% depending on the diagnostic criteria applied.Its etiology involves both geneticand environmental factors. Typically, women with PCOS show clinical and biochemical hyperandrogenism,oligoanovulation, and micropolycystic morphology of the ovaries. Unani formulation containingNankhwah , Badiyan and Wajturki possessing the properties of Mudirr-i-Bawl-o- Hayd, mujaff –i-Balgham ,Munaffis-i- balgham , Muhallil, Muqawwi-i-Jigar were used in the form of Joshanda 6gm BDStarting from 5 days prior to expected period date to 5 days during menses for 3 cycles, which led to regainregularity of menses, correcting the amount of flow and reducing the ovarian volume on US. Thus unanimedications have the potential to treat ths symtoms of PCOS and improve the quality of life of women.
Abstract
PCOS is the most common endocrine pathology in females of reproductive worldwide. The prevalenceranges between 5% and 15% depending on the diagnostic criteria applied.Its etiology involves both geneticand environmental factors. Typically, women with PCOS show clinical and biochemical hyperandrogenism,oligoanovulation, and micropolycystic morphology of the ovaries. Unani formulation containingNankhwah , Badiyan and Wajturki possessing the properties of Mudirr-i-Bawl-o- Hayd, mujaff –i-Balgham ,Munaffis-i- balgham , Muhallil, Muqawwi-i-Jigar were used in the form of Joshanda 6gm BDStarting from 5 days prior to expected period date to 5 days during menses for 3 cycles, which led to regainregularity of menses, correcting the amount of flow and reducing the ovarian volume on US. Thus unanimedications have the potential to treat ths symtoms of PCOS and improve the quality of life of women.
참고문헌 (17)
- Sadeghi, H. M., "Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing", 23, pp.583~ (2022)
- MUHAS, "POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW", 10, pp.5~9 (2018)
- Yasmin, A., "olycystic ovary syndrome: An updated overview foregrounding impacts of ethnicities and geographic variations", 12, pp.1974~ (2022)
- Witchel, S. F., "Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls", 3, pp.1545~1573 (2019)
- Louwers, Y. V., "Characteristics of polycystic ovary syndrome throughout life", 14, pp.2633494120911038~ (2020)
- Zeng, L.-H., "Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies", 13, pp.874914~ (2022)
- Escobar-Morreale, H. F. J. N. R. E., "Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment", 14, pp.270~284 (2018)
- Bulsara, J., "A review: Brief insight into Polycystic Ovarian syndrome", 3, pp.100085~ (2021)
- Bashir, A., "Comprehension, management, and treatment of polycystic ovarian syndrome via allopathic, Unani and ayurvedic perspectives", 21, pp.1~9 (2021)
- Firdose, K. F., "An approach to the management of poly cystic ovarian disease in Unani system of medicine: A review", 2, pp.585~590 (2016)
- Syed, A. F., "Marz Akyas Khusyatur Rehm (Polycystic Ovary Syndrome): An Overview", 3, pp.119~128 (2016)
- Sheeraz, M., "Concept and management of Polycystic Ovarian Syndrome In Greco Arabian Medicine: A Review Study", World Journal of Pharmaceutical Research, 7, pp.487~501 (2020)
- Hakeem, H. M. A., "Bustanul Mufradath", New Delhi, 56 (2002)
- H., K. Makhzanul Mufradath, , ~ (2007)
- Naquvi, K. J., "A review on phytochemical investigations and biological activities of Trachyspermum ammi (L.) sprague", 15, pp.2364~2370 (2022)
- Debnath, S., "Foeniculum vulgare from Spice to Pharma: Recent Advances in Its Medicinal Value, Bioactivities and Perspectives", pp.217~229 (2023)
- kharat SR, S. P., "An overview on Vacha (Acorus calamus L.) with special reference to Ayurvedic and modern aspect", International Journal of Pharmaceutical Research and Applications, 8(2), pp.594~601 (2023)